Josef Stehlik, M.D., M.P.H.

Education and Training:

Medical School: Charles University, 1st Faculty of Medicine, Prague
Residency: Allegheny General Hospital, MCP * Hahnemann University, Pittsburgh, PA
Clinical Fellowships:

• Allegheny General Hospital, MCP * Hahnemann University, Pittsburgh, PA
• Cleveland Clinic Foundation, Cleveland, OH
• Harvard School of Public Health, Boston, MA (MPH)

Clinical Specialties:

• Heart Failure
• Cardiac Transplantation

Research Interests:

• Heart Failure
• Cardiac Transplantation

Recent Publications:

• Stehlik J, Nelson D, Kfoury AG, Reid BB, Clayson SE, Nelson KE, Christensen BJ, Renlund DG, Movsesian MA, Cowley CG, Smith HK, Rasmusson BY, Long JW. Outcome of Non-cardiac Surgery in Patients with Ventricular Assist Devices. Am J Cariol. Apr 2009.
• Stehlik J, Movsesian MA. Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure. Journal of Cardiac Failure. 2009
• Kfoury AG, Renlund DG, Snow GL, Stehlik J, Folsom JW et al. Clinical Correlation Study of Severity of Antibody-mediated Rejection and Cardiovascular Mortality in Heart Transplantation. J Heart Lung Transplant. 2009 Jan;28(1):51-7.Epub 2008 Dec 4
• Movsesian MA, Stehlik J, Vandeput F, Bristow MR. Phosphodiesterase inhibition in heart failure. Heart Fail Rev. 2008 Dec 19.
• Kfoury AG, Hammond ME, Snow GL, Stehlik J, Reid BB, Long JW, Gilbert EM, Bader FM, Bull DA, Renlund DG. Early screening for antibody-mediated rejection in heart transplant recipients. J Heart Lung Transplant. 2007 Dec;26(12):1264-9. Epub 2007 Nov 26.
• Rasmusson KD, Stehlik J, Brown RN, Renlund DG, Wagoner LE, Torre-Amione G, Folsom JW, Silber DH, Kirklin JK: Long-Term Outcomes of Transplantation for Peripartum Cardiomyopathy. A Multi-institutional Analysis. J Heart Lung Transplant. 2007 Nov:26(11):1097-104.
• Stehlik J, Starling RC, Movsesian MA, Fang JC, Brown RN, Lewis NP, Hess ML, Kirklin JK. Utility of Long-Term Surveillance Endomyocardial Biopsy. A Multiinstitutional Analysis. J Heart Lung Transplant 25:1402-1409, 2006. J Heart Lung Transplant.
• Kfoury AG, Stehlik J, Renlund DG, Snow G, Seaman JT, Gilbert EM, Stringham JS, Long JW, Hammond ME: The Impact of Repetitive Episodes of Antibody-Mediated Or Cellular Rejection On Cardiovascular Mortality In Cardiac Transplant Recipients: Defining Rejection Patterns; J Heart Lung Transplant; 2006 Nov;25(11):1277-82. Epub 2006 Oct 16.
• Hammond ME, Stehlik J, Snow G, Renlund DG, Seaman J, Dabbas B, Gilbert EM, Stringham JC, Long JW, Kfoury AG. Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies. J Heart Lung Transplant. 2005 Dec;24(12):2015-21.
• Stehlik J, Movsesian MA. Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure. Expert Opin Investig Drugs. 2006 Jul;15(7):733-42.

Hide complete profile.